---

---

entities : Novartis ag    crawled time : 10:00   

save search

---

Viral Vector and Plasmid DNA Technologies: A Global Market Perspective
Published: 2024-04-17 (Crawled : 10:00) - prnewswire.com
TMO | News | $576.13 0.27% 1.1M |

Health Technology

| 1.46% | O: -0.26% H: 0.03% C: -1.55%
NVS | News | $98.1 0.84% 1.3M |

Health Technology

| 6.51% | O: 0.87% H: 0.16% C: -0.59%
RGNX | $15.75 -0.94% 120K |

Health Technology

| -10.9% | O: -1.43% H: 2.27% C: -3.18%
global dna market

---

BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer
Published: 2024-03-20 (Crawled : 10:00) - globenewswire.com
NVSEF | News | $96.0 52K |

Health Technology

| -0.93% | O: -1.37% H: 0.0% C: -1.58%
NVS | News | $98.1 0.84% 1.3M |

Health Technology

| 2.64% | O: -0.62% H: 0.45% C: 0.34%
BNTX | News | $88.185 -0.35% 140K |

Health Technology

| -5.98% | O: -5.51% H: 1.33% C: 1.2%
management commercial

---

Orphan Drugs Market Projection: BCC Research Anticipates a Staggering $415.2 Billion Valuation by 2028, Reflecting Soaring Global Demand
Published: 2024-02-09 (Crawled : 10:00) - prnewswire.com
ALPMF | News | $9.5 1.2K |

Health Technology

| -13.24% | O: -0.91% H: 3.88% C: 3.88%
AZNCF | News | $140.3 1.5K |

Health Technology

| 12.24% | O: -2.6% H: 2.26% C: 1.44%
NVSEF | News | $96.0 52K |

Health Technology

| -7.06% | O: -2.46% H: 0.0% C: 0.0%
ALPMY | News | $9.49 480K |

Manufacturing

| -11.56% | O: 4.66% H: 0.0% C: -3.92%
PFE | News 4 | $26.25 -0.27% 12M |

Health Technology

| -4.53% | O: -0.04% H: 0.11% C: 0.0%
NVS | News | $98.1 0.84% 1.3M |

Health Technology

| -2.47% | O: -0.37% H: 0.21% C: 0.05%
ABBV | News | $168.21 -0.78% 1.2M |

Health Technology

| -2.8% | O: 0.33% H: 0.0% C: 0.0%
SNY | News | $46.765 -1.94% 950K |

Health Technology

| 2.1% | O: 1.11% H: 0.0% C: 0.0%
AZN | News | $71.26 0.58% 3.8M |

Health Technology

| 11.54% | O: -1.28% H: 1.05% C: -0.72%
research global market

---

United States Endometrial Cancer Research Report 2023
Published: 2024-02-02 (Crawled : 10:00) - prnewswire.com
TAK | News | $13.265 -0.86% 540K |

Health Technology

| -7.2% | O: 0.21% H: 0.49% C: -0.9%
NVS | News | $98.1 0.84% 1.3M |

Health Technology

| -6.14% | O: -0.5% H: 0.26% C: -1.03%
report cancer research

---

Global Home Infusion Therapy Market Report 2023: A $38.71 Billion Industry by 2028 - Emerging Potential in Chemotherapy and Expansion of Specialty Medications and Biologics
Published: 2023-12-14 (Crawled : 10:00) - prnewswire.com
TRUMF | $16.608 5.6K |

Health Technology

| -48.44% | O: 4.56% H: 0.02% C: -1.7%
TRUMY | $17.05 47K |

Manufacturing

| -48.86% | O: 0.19% H: 1.5% C: -1.11%
NVS | News | $98.1 0.84% 1.3M |

Health Technology

| -0.85% | O: -1.67% H: 1.17% C: 0.85%
BDX | $233.97 -0.17% 420K |

Health Technology

| -2.54% | O: 0.71% H: 0.48% C: -1.52%
ICUI | $96.39 -1.4% 46K |

Health Technology

| 6.13% | O: 3.37% H: 6.0% C: 5.44%
report expansion global home potential therapy market

---

Novartis Kisqali® NATALEE analysis reinforces consistent reduction in risk of recurrence across key subgroups of patients with early breast cancer
Published: 2023-10-20 (Crawled : 10:00) - globenewswire.com
PFE | News 4 | $26.25 -0.27% 12M |

Health Technology

| -15.61% | O: -0.42% H: 0.16% C: -1.32%
NVS | News | $98.1 0.84% 1.3M |

Health Technology

| 4.46% | O: 0.6% H: 0.61% C: -0.56%
kisqali breast cancer risk novartis

---

Novartis shareholders approve the proposed 100% Spin-off of Sandoz
Published: 2023-09-15 (Crawled : 10:00) - globenewswire.com
NVSEF | News | $96.0 52K |

Health Technology

| 13.27% | O: 0.79% H: 0.0% C: 0.0%
NVS | News | $98.1 0.84% 1.3M |

Health Technology

| -2.92% | O: 1.51% H: 0.26% C: -0.72%
novartis

---

Global Skeletal Dysplasia Markets Report 2023: A $3.66 Billion Market by 2027 - From Diagnosis to Innovations, Unveiling the Potential of the Growing Market
Published: 2023-08-25 (Crawled : 10:00) - prnewswire.com
NVS | News | $98.1 0.84% 1.3M |

Health Technology

| -1.96% | O: 0.67% H: 0.37% C: 0.26%
LLY | News | $735.1 -1.42% 1.2M |

Health Technology

| 33.33% | O: -0.84% H: 1.18% C: 0.73%
REGN | News | $909.39 0.23% 210K |

Health Technology

| 7.74% | O: -1.14% H: 0.3% C: -0.26%
report global growing potential market

---

Environmental Factors and Advancements in Immunotherapies Propel Growth of Global Allergy Treatment Market to 2027
Published: 2023-08-10 (Crawled : 10:00) - prnewswire.com
GLAXF | News | $19.54 2.6K |

Health Technology

| 11.85% | O: 0.63% H: 0.0% C: -2.67%
NVSEF | News | $96.0 52K |

Health Technology

| 13.78% | O: 2.5% H: 0.0% C: -0.11%
NVS | News | $98.1 0.84% 1.3M |

Health Technology

| -4.34% | O: 0.13% H: 0.72% C: -0.18%
JNJ | News | $148.515 -0.7% 4.3M |

Health Technology

| -13.35% | O: 0.75% H: 1.13% C: -1.05%
GSK | News | $40.905 -0.81% 890K |

Health Technology

| 17.23% | O: 0.0% H: 0.61% C: -0.28%
BHC | $8.56 0.35% 590K |

Health Technology

| -1.04% | O: -0.23% H: 1.22% C: -2.21%
ABBV | News | $168.21 -0.78% 1.2M |

Health Technology

| 12.59% | O: 0.41% H: 1.08% C: 0.16%
SNY | News | $46.765 -1.94% 950K |

Health Technology

| -10.6% | O: 1.52% H: 1.05% C: 0.47%
propel treatment global growth market

---

Biosimilars Market worth $66.9 billion | MarketsandMarkets
Published: 2023-06-15 (Crawled : 10:00) - prnewswire.com
PFE | News 4 | $26.25 -0.27% 12M |

Health Technology

| -33.13% | O: 0.13% H: 1.07% C: 0.86%
NVS | News | $98.1 0.84% 1.3M |

Health Technology

| -0.82% | O: 1.04% H: 0.78% C: 0.67%
LLY | News | $735.1 -1.42% 1.2M |

Health Technology

| 65.07% | O: 0.06% H: 1.91% C: 1.32%
AMGN | News | $274.15 0.22% 900K |

Health Technology

| 23.06% | O: 0.33% H: 2.62% C: 2.43%
market

---

Non-Alcoholic Steatohepatitis Biomarkers Market Booming: Projected Market Value of US$ 8177.9 billion and CAGR of 31.3%
Published: 2023-05-18 (Crawled : 10:00) - prnewswire.com
PFE | News 4 | $26.25 -0.27% 12M |

Health Technology

| -28.38% | O: -0.11% H: 0.19% C: -0.63%
NVO | News | $126.09 -1.98% 2.2M |

Health Technology

| -23.02% | O: 0.44% H: 0.51% C: 0.43%
NVS | News | $98.1 0.84% 1.3M |

Health Technology

| -2.33% | O: -0.49% H: 0.42% C: -0.37%
biomarkers market

---

Cell and Gene Therapy Market Projected to Grow at a CAGR of 22.8% and Reach US$ 62.5 Billion by 2032
Published: 2023-05-03 (Crawled : 10:00) - prnewswire.com
NVSEF | News | $96.0 52K |

Health Technology

| 12.94% | O: -1.96% H: 0.0% C: 0.0%
NVS | News | $98.1 0.84% 1.3M |

Health Technology

| -4.52% | O: 0.55% H: 0.68% C: 0.33%
reach cell therapy market

---

Novartis Phase III APPOINT-PNH trial shows investigational oral monotherapy iptacopan improves hemoglobin to near-normal levels, leading to transfusion independence in all treatment-naïve PNH patients
Published: 2023-04-26 (Crawled : 10:00) - globenewswire.com
NVSEF | News | $96.0 52K |

Health Technology

| 10.34% | O: 0.0% H: 0.0% C: 0.0%
NVS | News | $98.1 0.84% 1.3M |

Health Technology

| -4.98% | O: 0.62% H: 0.0% C: -2.04%
transfusion novartis trial

---

The Glioblastoma Multiforme (GBM) Treatment Market Overview: Market Size, Expected CAGR, Growth Driver And Major Players
Published: 2023-04-13 (Crawled : 10:00) - prnewswire.com
AZNCF | News | $140.3 1.5K |

Health Technology

| -4.72% | O: 0.0% H: 1.63% C: 1.63%
NVSEF | News | $96.0 52K |

Health Technology

| 19.63% | O: 1.25% H: 0.51% C: 0.51%
NVS | News | $98.1 0.84% 1.3M |

Health Technology

| 2.48% | O: 1.3% H: 0.56% C: 0.51%
AZN | News | $71.26 0.58% 3.8M |

Health Technology

| -3.95% | O: 0.39% H: 1.05% C: 0.97%
AMGN | News | $274.15 0.22% 900K |

Health Technology

| 9.64% | O: -0.36% H: 1.33% C: 1.14%
expected treatment growth glioblastoma market

---

Lung Cancer Drugs Global Market Research Report 2023 Featuring Bristol-Myers Squibb, Merck, F. Hoffmann-La Roche, Novartis, Pfizer, GlaxoSmithKline, Vertiv, Sanofi-Aventis, Sun Pharma and Celgene
Published: 2023-02-24 (Crawled : 10:00) - prnewswire.com
SNYNF | News | $94.25 480 |

Health Technology

| -2.94% | O: -2.11% H: 0.0% C: 0.0%
NVS | News | $98.1 0.84% 1.3M |

Health Technology

| 14.24% | O: -0.25% H: 0.03% C: -0.81%
BMY | $48.825 -0.34% 9.7M |

Health Technology

| -31.39% | O: -0.41% H: 0.15% C: -1.31%
SNY | News | $46.765 -1.94% 950K |

Health Technology

| -0.97% | O: 0.72% H: 0.0% C: 0.0%
lung pharma research global report cancer market

---

Alpha Glucosidase inhibitors market size to increase by USD 567.96 million by 2026; North America to account for 42% of market growth - Technavio
Published: 2023-02-17 (Crawled : 10:00) - prnewswire.com
AZNCF | News | $140.3 1.5K |

Health Technology

| 1.71% | O: 0.59% H: 0.22% C: -1.69%
NVS | News | $98.1 0.84% 1.3M |

Health Technology

| 15.01% | O: -0.24% H: 1.61% C: 1.52%
SNY | News | $46.765 -1.94% 950K |

Health Technology

| 0.59% | O: 1.22% H: 0.0% C: 0.0%
AZN | News | $71.26 0.58% 3.8M |

Health Technology

| 4.27% | O: 0.43% H: 1.47% C: 1.07%
america growth market

---

Regenerative Medicine Market to be Worth $180.87 Billion by 2030: Grand View Research, Inc.
Published: 2023-02-14 (Crawled : 10:00) - prnewswire.com
AZNCF | News | $140.3 1.5K |

Health Technology

| 0.73% | O: 0.43% H: 1.52% C: -1.88%
NVSEF | News | $96.0 52K |

Health Technology

| 32.07% | O: 0.34% H: 0.0% C: 0.0%
USRM | $0.0001 1300.0% 290K |

Professional, Scientific, and T...

| -97.78% | O: 2.22% H: 4.35% C: 4.35%
PFE | News 4 | $26.25 -0.27% 12M |

Health Technology

| -40.17% | O: 0.23% H: 0.25% C: -0.84%
NVS | News | $98.1 0.84% 1.3M |

Health Technology

| 13.0% | O: 0.27% H: 0.42% C: -0.21%
LLY | News | $735.1 -1.42% 1.2M |

Health Technology

| 110.92% | O: 0.04% H: 0.93% C: -0.85%
NUVA | $39.75 -2.24% -2.29% 0 |

Health Technology

| -10.15% | O: -0.16% H: 2.24% C: 0.79%
MDXG | $6.44 -1.08% 210K |

Health Technology

| 40.91% | O: -1.3% H: 2.85% C: 2.19%
AZN | News | $71.26 0.58% 3.8M |

Health Technology

| 1.64% | O: 0.3% H: 0.94% C: 0.6%
AMGN | News | $274.15 0.22% 900K |

Health Technology

| 12.26% | O: -0.39% H: 0.12% C: -0.69%
market

---

Eye Care Surgical Devices Market: A Deep Dive Into Factors that will Help Vendors Stay Ahead of Competitors - Technavio
Published: 2022-09-14 (Crawled : 10:00) - prnewswire.com
NVS | News | $98.1 0.84% 1.3M |

Health Technology

| 20.63% | O: -0.55% H: 0.42% C: -0.72%
BHC | $8.56 0.35% 590K |

Health Technology

| 15.9% | O: 0.41% H: 11.64% C: 6.22%
ALC | $79.935 -1.02% 350K |

Health Technology

| 19.72% | O: -0.56% H: 1.7% C: 1.01%
care eye

---

Macular Degeneration Treatment Global Market to Reach $10.65 Billion by 2026 at a CAGR of 7.15%
Published: 2022-09-14 (Crawled : 10:00) - prnewswire.com
GLAXF | News | $19.54 2.6K |

Health Technology

| 27.09% | O: -4.98% H: 7.63% C: 2.67%
NVS | News | $98.1 0.84% 1.3M |

Health Technology

| 20.63% | O: -0.55% H: 0.42% C: -0.72%
GSK | News | $40.905 -0.81% 890K |

Health Technology

| 30.38% | O: -0.6% H: 0.41% C: -0.76%
BHC | $8.56 0.35% 590K |

Health Technology

| 15.9% | O: 0.41% H: 11.64% C: 6.22%
RGNX | $15.75 -0.94% 120K |

Health Technology

| -39.61% | O: 0.38% H: 2.53% C: 1.48%
treatment global macular market

---

Surgical Pliers Market Size worth USD 144.28 Mn by 2026, Market Analysis Segmented by Type and Geography
Published: 2022-09-13 (Crawled : 10:00) - prnewswire.com
STE | $204.05 -0.94% 140K |

Health Technology

| -2.83% | O: -1.5% H: 0.82% C: -1.68%
NVS | News | $98.1 0.84% 1.3M |

Health Technology

| 18.25% | O: -0.72% H: 0.07% C: -1.27%
MDT | $80.37 -1.13% 2.6M |

Health Technology

| -11.7% | O: -1.73% H: 1.41% C: -0.17%
market

---

Gainers vs Losers

58%

42%

Top 10 Gainers

CZOO | $10.52 110.82% 10M |

CSSE 4 | $0.3181 108.86% 170M |

Consumer Services

BOF | $1.88 60.68% 98M |

AMST | $3.1 55.0% 66M |

Technology Services

LICN | $0.85 51.79% 13M |

WIMI | $1.03 41.99% 15M |

Technology Services

SKIL 4 | $8.045 40.89% 230K |

Information

MULN | News | $3.805 39.38% 11M |

Information

RILY | $30.01 38.17% 11M |

Finance

MTC | $3.04 35.71% 6.7M |

Technology Services

---

Your saved searches

---